Exelixis
EXEL
#1638
Rank
A$18.61 B
Marketcap
A$74.06
Share price
0.02%
Change (1 day)
14.21%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company